G. Sakoulas  Clinical Microbiology and Infection 

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
L. Boyanova  Clinical Microbiology and Infection 
Clinical Microbiology and Infection
Gut bacterial microbiota and obesity
Approach to diagnosis of infective endocarditis
Incidence and outcome of Staphylococcus aureus endocarditis—a 10-year single-centre northern European experience  H. Asgeirsson, A. Thalme, M. Kristjansson,
R. Colodner, O. Nitzan, B. Chazan, H. Edelstein, R. Raz 
Time-trends for Gram-negative and multidrug-resistant Gram-positive bacteria associated with nosocomial infections in German intensive care units between.
Herpes zoster in non-hospitalized children
European Society of Clinical Microbiology and Infectious Diseases (ESCMID): Data review and recommendations for diagnosing Clostridium difficile-infection.
Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications  T.-L. Liao, Y.-M.
Migrant health—a cause for concern?
Current management of patients hospitalized with complicated skin and soft tissue infections across Europe (2010–2011): assessment of clinical practice.
European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after.
Clinical characteristics of Haemophilus influenzae meningitis in Denmark in the post- vaccination era  T.I. Pedersen, M. Howitz, C. Østergaard  Clinical.
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
R. Cantón  Clinical Microbiology and Infection 
Genital Chlamydia trachomatis infections
European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after.
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia  D. Kese, M. Maticic, M. Potocnik  Clinical.
J.-P. Stahl  Clinical Microbiology and Infection 
J. Cairo, R. Hachem, G. Rangaraj, B. Granwehr, I. Raad 
Evaluation of viral co-infections in hospitalized and non-hospitalized children with respiratory infections using microarrays  S. Kouni, P. Karakitsos,
Surveillance of Legionnaires’ disease in Austria
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Escherichia coli native valve endocarditis
Vector control: a cornerstone in the malaria elimination campaign
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Field evaluation of a second-generation cytometer UF-100 in diagnosis of acute urinary tract infections in adult patients  F. Manoni, S. Valverde, F.
Training for the infectious diseases speciality in Norway
F. Grill, P. Muñoz, R. Jofre, E. Bouza 
P. Seng, J.M. Rolain, D. Raoult, P. Brouqui 
Effects of gentamicin monotherapy for the initial treatment of community-onset complicated non-obstructive acute pyelonephritis due to Enterobacteriaceae.
M. Roche, H. Humphreys, E. Smyth, J. Phillips, R. Cunney, E
Levofloxacin in the treatment of ventilator-associated pneumonia
Evolving epidemiology of invasive Haemophilus infections in the post-vaccination era: results from a long-term population-based study  M.R. Berndsen,
Metagenomics and probiotics
Risk factors for extended-spectrum β-lactamase-producing Escherichia coli urinary tract infection in the community in Denmark: a case–control study  M.
Laboratory diagnosis of Clostridium difficile disease
The practice of travel medicine in Europe
Abstracts cont. Clinical Microbiology and Infection
Pandemic lineages of extraintestinal pathogenic Escherichia coli
A.W. Karchmer  Clinical Microbiology and Infection 
Testing patients with non-specific symptoms for antibodies against Borrelia burgdorferi sensu lato does not provide useful clinical information about.
Single-dose ciprofloxacin versus 3 days of norfloxacin in uncomplicated urinary tract infections in women  F. Auquer, F. Cordón, E. Gorina, J.C. Caballero,
Current experience in treating invasive zygomycosis with posaconazole
V. Spoorenberg, J. M. Prins, B. C. Opmeer, T. M. de Reijke, M. E. J. L
Correlation between time to positivity of blood cultures with clinical presentation and outcomes in patients with Klebsiella pneumoniae bacteraemia: prospective.
G.M. Rossolini, E. Mantengoli  Clinical Microbiology and Infection 
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Active surveillance of antibiotic resistance prevalence in urinary tract and skin infections in the outpatient setting  A. Kronenberg, S. Koenig, S. Droz,
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin 
Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre  R.R. Laffer, P. Graber, P.E. Ochsner, W. Zimmerli 
Abstracts Clinical Microbiology and Infection
Modelling during an emergency: the 2009 H1N1 influenza pandemic
B.A. Cunha  Clinical Microbiology and Infection 
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Three years experience of real-time PCR for the diagnosis of Q fever
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Clinical outcomes with daptomycin: a post-marketing, real-world evaluation  G. Sakoulas  Clinical Microbiology and Infection  Volume 15, Pages 11-16 (December 2009) DOI: 10.1111/j.1469-0691.2009.03054.x Copyright © 2009 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Infection types of the 2332 patients (includes non-evaluable patients) treated with daptomycin in 2004 and 2005 [25]. cSSTI, complicated skin and soft tissue infection; IE, infective endocarditis; uSSTI, uncomplicated skin and soft tissue infection. *Other: foreign-body infections, septic arthritis, urinary tract infections, central nervous system infections, and necrotizing infections. Clinical Microbiology and Infection 2009 15, 11-16DOI: (10.1111/j.1469-0691.2009.03054.x) Copyright © 2009 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.